BREAKING
Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 1 hour ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 3 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 5 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 7 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 8 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 9 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 9 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 12 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 12 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 13 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 1 hour ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 3 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 5 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 7 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 8 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 9 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 9 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 12 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 12 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 13 hours ago
ADVERTISEMENT
Market News

Baxter International Inc. (BAX) Q3 2019 Earnings Snapshot

— Baxter International Inc. (NYSE: BAX) reported third-quarter 2019 revenues of $2.85 billion, up 3% YoY, vs. $2.86 billion expected. — Operating income on an adjusted basis totaled $555 million, or 19.5% of sales. — The company has launched an internal probe into transactions undertaken for the purpose of generating foreign exchange gains or losses. […]

$BAX October 24, 2019 1 min read

— Baxter International Inc. (NYSE: BAX) reported third-quarter 2019 revenues of $2.85 billion, up 3% YoY, vs. $2.86 billion expected.

— Operating income on an adjusted basis totaled $555 million, or 19.5% of sales.

— The company has launched an internal probe into transactions undertaken for the purpose of generating foreign exchange gains or losses. The transactions used a convention that was not in accordance with GAAP, leading to some misstatements in the previously reported operating income. Baxter did not give an end date for the probe.

— For 4Q19, Baxter sees sales growth of 3-4% on a reported basis and approximately 5% on a constant currency basis. Operating margin is expected between 15.2% and 15.9% on a reported basis and between 18.5% and 19% on an adjusted basis.

— BAX shares fell 6.5 immediately following the earnings announcement.

ADVERTISEMENT

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

ADVERTISEMENT